Tramadol, buy tramadol, antibiotics, Weight Loss drugs, weight loss herbs, weight loss herbal formula, weight loss, hair loss, hair growth, baldness, Rx Online, pharmaceuticals, DHEA, Lutein, Prescription, Prescription drug, prescription medications, melanin.

DreamPharm Products:

Lutein-20||Herbs for headache, fever, and migraine || Milk thistle||Saw palmetto|| Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract|| Ginseng and Ginkgo||Hair Million|| DHEA||Coenzyme Q10|| Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.|| Weight loss herbal formula||Ginkgo biloba|| Colon cleansing, Laxative for constipation relief, laxative, and colon cleansing||ViaVita, Lecithin for healthy liver

Interferon research abs 1 || Hemoglobin research abs || Stem cell research abs || Nucleic acid research abs || Herpes research abs || Bronchitis research abs || Schizophrenia research abs || Tuberculosis research abs || Pneumonia research abs || Constipation research abs || Laxative research abs || hair research abs || hair related research references || testosterone related research references || melanin related research references

Acta Neuropathol (Berl). 1999 Apr;97(4):408-12.
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.

Wullner U, Kornhuber J, Weller M, Schulz JB, Loschmann PA, Riederer P, Klockgether T.

Department of Neurology, Friedrich-Wilhelms-University, Bonn, Germany. wuellneni-bonn.de

We studied the substantia nigra of three Parkinson's disease (PD) patients and three age-matched individuals by in situ DNA-end labeling (ISEL) and immunohistochemistry for the apoptosis regulating proteins Bcl-2, Bax and Bcl-x on 50 consecutive sections per patient. No melanin-containing cell was identified with typical apoptotic changes in either patient or control substantia nigra. With prolonged reaction-time the terminal transferase-mediated DNA-end labeling revealed a signal in 2.0 +/-1.2% melanin-containing cells in PD compared to 1.3 +/-1.1% in control. This difference did nor reach statistical significance and no condensation or margination of the chromatin was evident. No significant changes of any of the apoptosis regulating proteins were apparent in PD substantia nigra. These findings do not support the hypothesis that apoptosis plays a central role in the pathogenesis of PD.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10208281&dopt=Abstract

Mod Pathol. 2003 May;16(5):481-90.
PNL2, a New Monoclonal Antibody Directed against a Fixative-Resistant Melanocyte Antigen.

Rochaix P, Lacroix-Triki M, Lamant L, Pichereaux C, Valmary S, Puente E, Al Saati T, Monsarrat B, Susini C, Buscail L, Delsol G, Voigt JJ.

Laboratoire d'anatomie et cytologie pathologiques, Institut Claudius Regaud (PR, ML-T, J-JV).

We report the production of a new monoclonal antibody, PNL2, directed against a fixative resistant melanocyte antigen. The analysis of PNL2 immunostaining on a broad range of normal or malignant human tissues and on various melanocytic lesions revealed its high specificity. PNL2 gave a strong cytoplasmic staining of skin and oral mucosae melanocytes, and staining of granulocytes when used at high concentration. PNL2 stained all intra-epidermal nevi irrespective of their histologic type, but common intradermal nevi and the dermal component of compound nevi were largely non-reactive as only scattered nevus cells in the papillary dermis were labeled. PNL2 labeled more than 70% of the neoplastic cells in all primary melanomas irrespective of their histologic type. However, PNL2 did not label desmoplastic melanomas. All metastatic melanomas were also stained but the percentage of labeled cells was occasionally lower than the primary tumor. PNL2, as anti-Melan A and HMB-45 antibodies, stained most of the clear cell sarcoma cells, and a few cells in angiomyolipomas and lymphangioleiomyomatosis. None of the other non-melanocytic lesions tested were labeled. Proteomic approaches showed that the immunoaffinity purified PNL2-binding complexes isolated from melanoma cell lines comprise at least TAP1, Clathrin 17 and prealbumin proteins, but not the gp100 recognized by HMB-45. In conclusion, this new monoclonal antibody, PNL2, is directed against a new fixative resistant melanocyte associated antigen. This antigen is chemically resistant and thus allows immunostaining after melanin bleaching or decalcification. We also demonstrate that it is different from Melan A and from gp100, even if PNL2 and HMB-45 staining patterns are sometimes similar.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12748255&dopt=Abstract [PubMed - in process]

Natl Toxicol Program Tech Rep Ser. 1986 Sep;310:1-206.
NTP Toxicology and Carcinogenesis Studies of Marine Diesel Fuel (NO CAS) and JP-5 Navy Fuel (CAS No. 8008-20-6) in B6C3F1 Mice (Dermal Studies).

National Toxicology Program.

Toxicology and carcinogenesis studies were conducted by applying marine diesel fuel or JP-5 navy fuel to clipped dorsal interscapular skin of male and female B6C3F1 mice to determine both systemic and dermal effects. Doses for the 2-year studies were set by conducting 14-day and 13-week studies. Doses of 2,000-40,000 mg/kg marine diesel fuel were applied neat in the 14-day studies; in the 13-week studies, doses of 250-4,000 mg/kg marine diesel fuel in acetone were applied with a dose volume of 0.1 ml. Doses of 5,000-40,000 mg/kg JP-5 navy fuel in ethanol were applied in the 14-day studies with a dose volume of 0.5 ml; in the 13-week studies, doses of 500-8,000 mg/kg JP-5 navy fuel in acetone were applied with a dose volume of 0.2 ml. For the 2-year studies, doses were selected which did not cause deaths, decrease body weight gain, or produce excessive dermatitis in the 14-day or 13-week studies. Two-year studies were conducted by administering marine diesel fuel or JP-5 navy fuel by dermal application to groups of 49 or 50 male and 50 female B6C3F1 mice at doses of 0, 250, or 500 mg/kg in an acetone vehicle with a dose volume of 0.1 ml. Both sexes of mice dosed with 500 mg/kg marine diesel fuel (84-week exposure) and female mice dosed with 500 mg/kg JP-5 navy fuel (90-week exposure) were killed early because of excessive irritation and ulceration at the site of application and to prevent the spread of infection. Survival rates at those times were 26/50 males and 29/50 females dosed with marine diesel fuel and 17/50 females dosed with JP-5 navy fuel. Survival rates at the end of the studies (104 weeks) were reduced (P<0.01) in low dose female mice receiving marine diesel fuel (40/50 in vehicle controls compared with 12/50 in the low dose group) or with JP-5 navy fuel (44/50 in vehicle controls compared with 33/50 in the low dose group). Body weight gain was decreased below that of the vehicle controls after week 30 in all groups of mice receiving marine diesel fuel and in both sexes of mice receiving the high dose of JP-5 navy fuel. There was a marked increase in the incidence of chronic dermatitis in mice receiving marine diesel fuel or JP-5 navy fuel. Chronic dermatitis was defined as a composite lesion of epidermal histopathologic changes generally consisting of acanthosis, hyperkeratosis, and in some instances necrosis and ulceration of the overlying epidermis. Dermal changes frequently included fibrosis, increased amounts of melanin, and the presence of acute and chronic inflammatory cell infiltrates. A dose-related, proportional increase in the severity of the lesions was twofold to threefold greater in the dosed groups than in the vehicle controls. The averagedegree of severity of the lesions was judged to be minimal in the vehicle controls, mild in the low dose groups, and moderate in the high dose groups of mice dosed with marine diesel fuel or JP-5 navy fuel. There were similar responses at the site of inguinal skin to which the chemicals had migrated after application, but the degree of severity of the lesions was judged to be minimal to mild in the vehicle control and dosed groups of mice. Squamous cell papillomas or carcinomas (combined) occurred with a positive trend (P<0.05) at the site of application in male mice administered marine diesel fuel (vehicle control, 0/49; low dose, 0/49; high dose, 3/49). The total numbers of mice with squamous cell papillomas or carcinomas (combined) both for the site of application and the adjacent inguinal skin were 1/50, 2/49, and 3/50 for the vehicle control, low dose, and high dose groups of male mice and 0/50, 1/45, and 2/48 for female mice. There are no NTP historical data for B6C3F1 mice that received acetone by dermal application. The NTP historical incidence of squamous cell papillomas or carcinomas (combined) in untreated male and female B6C3F1 mice is 0.3%-0.4% in over 3,500 observations. Marine diesel fuel was not mutagenic in Salmonella typhimurium TA98, TA100, TA1535, or TA1537, and JP-5 navy fuel was not mutagenic in strains TA97, TA98, TA100, or TA1535 in th100, or TA1535 in the presence or absence of Aroclor 1254-induced male Sprague-Dawley rat or male Syrian hamster S9 when tested according to the preincubation protocol. Audits of the experimental data were conducted for these 2-year studies on marine diesel fuel and JP-5 navy fuel. No data discrepancies were found that influenced the final interpretations. Under the conditions of these 2-year dermal studies, marine diesel fuel at doses of 250 and 500 mg/kg resulted in dose-related increased incidences of squamous cell neoplasms of the skin (primarily carcinomas), providing equivocal evidence of carcinogenicity for male and female B6C3F1 mice. The sensitivity for detecting systemic carcinogenicity in female mice dosed with marine diesel fuel was reduced by poor survival. Under the conditions of these 2-year dermal studies, JP-5 navy fuel at doses of 250 and 500 mg/kg provided no evidence of carcinogenicity for male and female B6C3F1 mice.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12748719&dopt=Abstract [PubMed - as supplied by publisher]

Sudden, and premature hair loss and baldness is a problem in many ways. Baldness is indeed becoming an increasing concern in the current aging society.
It changes personal appearance and identity in social context. Saw palmetto berry extract is a widely known herbfor hair loss as well as BPH problems in Western world. Saw palmetto berry contains phytochemicals that inhibits 5-alpha-reductase that converts testosterone to DHT.

There are a number of traditional herbs that could stop hair loss and promotes hair growth. Numerous personal experiences and anecdotal cases testify that the herbal formula based on the Chinese herbs improves the situation of the age-related hair thinning and hair loss for a large fraction of people taking it regularly. It is unknown how Hair Million herbs stop hair loss, and promote hair growth due to the lack of scientific research and placebo controlled clinical trials.

DHEA is a natural hormone, and it is produced in our body by the adrenal glands. DHEA has been suggested to provide numerous potential benefits. DHEA (or dehydroepiandrosterone) is converted into androgens (male hormones) or estrogens (female hormones) in the cells. Our bodies produce decreasing amount of DHEA as we get older. various health benefits: To deter aging, improve sexual function/erectile dysfunction, treat cognitive decline, enhance athletic performance, facilitate weight loss, improve strength, prevent osteoporosis, enhance immunomodulation for rheumatic conditions, and treat depression.

DreamPharm Online Healthy Supplements || Constipation relief, laxative, colon cleansing || Lutein || Progesterone Cream || Natural herbal formula for hair loss problems ||